Living Cell Technologies Limited

Ticker LCT

Exchange ASX More
Industry Biotechnology More
Sector Healthcare More

Based in Melbourne, Australia

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia. …More

Visit website

REPORT RATINGS

4.8 / 5.0 (95)

Living Cell Technologies Limited reports have an aggregate usefulness score of 4.8 based on 95 reviews.

Living Cell Technologies Limited